Every “AI in Healthcare 2026” Talk Says the Same Three Things. They Are All Incomplete.
中文摘要
2026年医疗AI讨论过度关注FDA审批，却忽视了影子工具、模型漂移及实施过程中的关键风险。
English Summary
Healthcare AI talks for 2026 focus too much on FDA approval, overlooking critical risks like shadow tools, model drift, and the complexities of implementation.
原文节选
FDA-approved is the wrong first question. The real risk lives one layer up, in the shadow tools, the drift, and the messy middle nobody… Continue reading on Medium »